For the purpose of this part, the following terms shall have the definitions ascribed to them in this section:
CHEMOTHERAPEUTIC WASTEAll waste generated by or resulting from the production or use of antineoplastic agents, used for the purpose of stopping or reversing the growth of malignant cells. Chemotherapeutic waste shall not include any waste containing antineoplastic agents that are listed as hazardous waste under 25 Pa. Code § 75.261 (relating to criteria, identification and listing of hazardous waste).
DANGEROUS WASTEInfectious wastes or chemotherapeutic wastes or hazardous wastes, or any combination thereof.
HAZARDOUS WASTEThe same as "hazardous waste" under the federal regulations promulgated by the United States Environmental Protection Agency and codified at 40 CFR 261.3 is incorporated by reference. All lists in 40 CFR, Part 261, Subpart D, and the appendixes to Part 261 are also expressly incorporated by reference. The term "hazardous waste" as used herein also includes any substance or mixture containing polychlorinated biphenyls (PCBs) at greater than 1/10 of 1% concentrations when such substance or mixture is not intended for beneficial use or reuse. Radioactive waste and by-products, as defined by the Code of Pennsylvania 1975, are expressly excluded from this definition.
HOSPITAL WASTEWaste of any sort generated by nursing homes, hospitals or clinics for the treatment of disease and like institutions or businesses. The term shall also include paper products, bedding, towels, containers or cleaning implements that have been exposed to infectious, chemotherapeutic, pathological wastes, solid wastes, and/or hazardous wastes generated by nursing homes, hospitals or clinics for the treatment of disease or like institutions or businesses.
INFECTIOUS WASTEWaste that contains or may contain any disease-producing microorganism or material. Infectious wastes include but are not limited to the following:
A. Those wastes that are generated by hospitalized patients who are isolated in separate rooms in order to protect others from their severe and communicable disease.
B. All cultures and stocks of etiologic agents.
C. All waste blood and blood products.
D. Tissues, organs, body parts, blood and body fluids that are removed during surgery and autopsy and other wastes generated by surgery or autopsy of septic cases or patients with infectious disease.
E. Wastes that were in contact with pathogens in any type of laboratory work, including collection containers, culture dishes, slides, plates and assemblies for diagnostic tests, and devices used to transfer, inoculate and mix cultures.
F. Sharps, including hypodermic needles, suture needles, disposal razors, syringes, pasteur pipettes, broken glass and scalpel blades.
G. Wastes that were in contact with the blood of patients undergoing hemodialysis at hospitals or independent treatment centers.
H. Carcasses and body parts of all animals which were exposed to zoonotic pathogens.
I. Animal bedding and other wastes that were in contact with diseased or laboratory research animals or their excretions, secretions, carcasses or body parts.
J. Waste biologicals (e.g., vaccines) produced by pharmaceutical companies for human or veterinary use.
K. Food and other products that are discarded because of contamination with etiologic agents.
L. Discarded equipment and equipment parts that are contaminated with etiologic agents and are to be discarded.
STORAGEThe holding of hazardous waste for a temporary period, at the end of which the hazardous waste is treated, disposed of, moved or stored elsewhere.
WASTEThe same as "solid waste" under federal regulations promulgated by the United States Environmental Protection Agency and codified at 40 CFR 261.2, which is incorporated by reference herein.